Natural products in neuroprotective therapies: Experimental and cheminformatics approaches to manage neurological disorders
Vol 7, Issue 1, 2024
VIEWS - 3257 (Abstract)
Abstract
Neurological disorders (NDs) such as Alzheimer’s disease (AD), Parkinson’s disease (PD), epilepsy, despondency, and dementia have been evidenced as a rising concern among diverse geographical regions. Brain-related diseases are currently the main concern because they increase mortality and morbidity in the elderly. Regardless of the continual efforts by modern scientists to develop a promising pharmacological or surgical management, the outcome has not been satisfactory. Also, due to synthetic drugs’ associated side effects, scientists have taken the initiative to consider using natural compounds as an alternative. Hence, they obtain pretty effective results by using natural compounds. Natural ingredients are synthesized from a variety of plant and animal sources. These natural ingredients cure brain diseases through a variety of mechanisms. For effective medication advancement, the molecules must go through preliminary clinical systems that require some investment and significant speculation. In this situation, cheminformatics is fundamental in diminishing time and venture. Cheminformatics methods play a significant role in these issues, including 3-dimensional quantitative structure-activity relationship 3D-(QSAR), virtual screening, docking, molecular dynamic studies, and quantum chemical studies. The vital purpose of this study is to disclose different types of NDs and the neuroprotective effect of several natural products for experimental and cheminformatics-based therapy. Natural products like green tea, flavonoids, and ginseng are discussed as effective neuroprotective products. However, more investigation is expected to comprehend the better utilization of regular items in future exploratory and cheminformatics-based treatment for NDs.
Keywords
Full Text:
PDFReferences
- Aizaz M, Lubna, Ahmad W, et al. Exploring the potential of halotolerant bacteria from coastal regions to mitigate salinity stress in wheat: physiological, molecular, and biochemical insights. Frontiers in Plant Science 2023. doi: 10.3389/fpls.2023.1224731.
- Gerique A. An introduction to ethnoecology and ethnobotany. Theory and Methods—Integrative assessment and planning methods for sustainable agroforestry in humid and semiarid regions. Available online: https://www.researchgate.net/publication/239591352_An_Introduction_to_ethnoecology_and_ethnobotany_Theory_and_Methods_-_Integrative_assessment_and_planning_methods_for_sustainable_agroforestry_in_humid_and_semiarid_regions. (accessed on 10 March 2023).
- Karthika C, Hari B, Mano V, et al. Curcumin as a great contributor for the treatment and mitigation of colorectal cancer. Experimental Gerontology 2021; 152: 111438. doi: 10.1016/j.exger.2021.111438.
- Kabir T, Tabassum N, Uddin S, et al. Therapeutic potential of polyphenols in the management of diabetic neuropathy. Evidence-Based Complementary and Alternative Medicine 2021; 2021: 9940169. doi: 10.1155/2021/9940169
- Avram S, Mernea M, Mihailescu D, Duda-Seiman D. Advanced QSAR methods evaluated polycyclic aromatic compounds duality as drugs and inductors in psychiatric disorders. Current Organic Chemistry 2013; 17(23): 2880–2890. doi: 10.2174/13852728113179990132
- Avram S, Milac AL, Mihailescu D. 3D-QSAR study indicates an enhancing effect of membrane ions on psychiatric drugs targeting serotonin receptor 5-HT1A. Molecular BioSystems 2012; 8(5): 1418. doi: 10.1039/c2mb00005a
- Walia V, Kaushik D, Mittal V, et al. Delineation of neuroprotective effects and possible benefits of antioxidantstherapy for the treatment of Alzheimer’s Diseases by targeting mitochondrial-derived reactive oxygen species: Bench to bedside. Molecular Neurobiology 2021; 59(1): 657–680. doi: 10.1007/s12035-021-02617-1
- Ouabbou S, He Y, Butler K, et al. Inflammation in mental disorders: Is the microbiota the missing link? Neuroscience Bulletin 2020; 36(9): 1071–1084. doi: 10.1007/s12264-020-00535-1
- Gober R, Ardalan M, Shiadeh SMJ, et al. Microglia activation in postmortem brains with schizophrenia demonstrates distinct morphological changes between brain regions. Brain Pathology 2021; 32(1): 13003. doi: 10.1111/bpa.13003
- Hurşitoğlu O, Orhan FÖ, Kurutaş EB, et al. Diagnostic performance of increased malondialdehyde level and oxidative stress in patients with schizophrenia. Arch Neuropsychiatry Turkish Neuropsychiatric Society 2021; 58(3): 184. doi: 10.29399/npa.27372
- Brown AS, Derkits EJ. Prenatal infection and schizophrenia: A review of epidemiologic and translational studies. American Journal of Psychiatry 2010; 167(3): 261–280. doi: 10.1176/appi.ajp.2009.09030361
- Rahman MH, Akter R, Bhattacharya T, et al. Resveratrol and neuroprotection: Impact and its therapeutic potential in Alzheimer’s Disease. Frontiers in Pharmacology 2020; 11: 619024. doi: 10.3389/fphar.2020.619024
- Ghose AK, Herbertz T, Hudkins RL, et al. Knowledge-based, Central Nervous System (CNS) lead selection and lead optimization for CNS drug discovery. ACS Chemical Neuroscience 2011; 3(1): 50–68. doi: 10.1021/cn200100h
- Sharma VK, Singh TG, Garg N, et al. Dysbiosis and Alzheimer’S Disease: A role for chronic stress? Biomolecules 2021; 11(5): 678. doi: 10.3390/biom11050678
- Hsu CW, Lee Y, Lee CY, Lin PY. Neurotoxicity and nephrotoxicity caused by combined use of lithium and risperidone: A case report and literature review. BMC Pharmacology and Toxicology 2016; 17(1): 59. doi: 10.1186/s40360-016-0101-x
- Nikolic K, Mavridis L, Djikic T, et al. Drug design for CNS diseases: Polypharmacological profiling of compounds using cheminformatic, 3D-QSAR and virtual screening methodologies. Frontiers in Neuroscience 2016; 10: 265. doi: 10.3389/fnins.2016.00265
- Crane EA, Gademann K. Capturing biological activity in natural product fragments by chemical synthesis. Angewandte Chemie International Edition 2016; 55(12): 3882–3902. doi: 10.1002/anie.201505863
- Bhattacharya T, Dey PS, Akter R, et al. Effect of natural leaf extracts as phytomedicine in curing geriatrics. Experimental Gerontology 2021; 150: 111352. doi: 10.1016/j.exger.2021.111352
- Akter R, Chowdhury MAR, Rahman MH. Flavonoids and polyphenolic compounds as potential talented agents for the treatment of alzheimer’s disease with their antioxidant activities. Current Pharmaceutical Design 2021; 27(3): 345–356. doi: 10.2174/1381612826666201102102810
- Tagde P, Tagde S, Tagde P, et al. Nutraceuticals and herbs in reducing the risk and improving the treatment of covid-19 by targeting sars-cov-2. Biomedicines 2021; 9(9): 1266. doi: 10.3390/biomedicines9091266
- Kabir MT, Rahman MH, Akter R, et al. Potential role of curcumin and its nanoformulations to treat various types of cancers. Biomolecules 2021; 11(3): 392. doi: 10.3390/biom11030392
- Xu J, Hagler A. Chemoinformatics and drug discovery. Molecules 2002; 7(8): 566–600. doi: 10.3390/70800566
- Ferreira LL, Andricopulo AD. From chemoinformatics to deep learning: An open road to drug discovery. Future Medicinal Chemistry 2019; 11(5): 371–374. doi: 10.4155/fmc-2018-0449
- Damale M, Harke S, Kalam Khan F, et al. Recent Advances in multidimensional QSAR (4D-6D): A critical review. Mini-Reviews in Medicinal Chemistry 2014; 14(1): 35–55. doi: 10.2174/13895575113136660104
- Avram S, Mernea M, Bagci E, et al. Advanced structure-activity relationships applied to Mentha spicata L. subsp. spicata essential oil compounds as AChE and NMDA ligands, in comparison with Donepezil, Galantamine and Memantine—New approach in brain disorders pharmacology. CNS & Neurological Disorders—Drug Targets 2017; 16(7): 800–811. doi: 10.2174/1871527316666170113115004
- Shinde RS, Deshmukh A, Navale VA. Cheminformatics tools useful for research scholar, research supervisor, research and developments. International Journal of Research and Analytical Reviews 2018; 5(4): 153–156.
- Avram S, Mernea M, Limban C, et al. Potential therapeutic approaches to Alzheimer’s disease by bioinformatics, cheminformatics and predicted adme-tox tools. Current Neuropharmacology 2020; 18(8): 696–719. doi: 10.2174/1570159x18666191230120053
- Peter SC, Dhanjal JK, Malik V, et al. Quantitative structure-activity relationship (QSAR): Modeling approaches to biological applications. In: Encyclopedia of Bioinformatics and Computational Biology: ABC of Bioinformatics. Elsevier; 2018; pp. 661–676.
- Andrade CH, Pasqualoto KFM, Ferreira EI, et al. 4D-QSAR: Perspectives in drug design. Molecules 2010; 15(5): 3281–3294. doi: 10.3390/molecules15053281
- Avram S, Milac AL, Carta F, et al. More effective dithiocarbamate derivatives inhibiting carbonic anhydrases, generated by QSAR and computational design. Journal of Enzyme Inhibition and Medicinal Chemistry 2012; 28(2): 350–359. doi: 10.3109/14756366.2012.727410
- Cherkasov A, Muratov EN, Fourches D, et al. QSAR modeling: Where have you been? Where are you going to? Journal of Medicinal Chemistry 2014; 57(12): 4977–5010. doi: 10.1021/jm4004285
- Cramer RD. The inevitable QSAR renaissance. Journal of Computer-Aided Molecular Design 2011; 26(1): 35–38. doi: 10.1007/s10822-011-9495-0
- Shoichet BK. Virtual screening of chemical libraries. Nature 2004; 432: 862–865. doi: 10.1038/nature03197
- Lavecchia A, Giovanni C. Virtual screening strategies in drug discovery: A critical review. Current Medicinal Chemistry 2013; 20(23): 2839–2860. doi: 10.2174/09298673113209990001
- Lenselink EB, Dijke N Ten, Bongers B, et al. Beyond the hype: Deep neural networks outperform established methods using a ChEMBL bioactivity benchmark set. Journal of Cheminformatics. 2017; 9(1): 45. doi: 10.1186/s13321-017-0232-0
- Yadav R, Selvaraj C, Aarthy M, et al. Investigating into the molecular interactions of flavonoids targeting NS2B-NS3 protease from ZIKA virus through in-silico approaches. Journal of Biomolecular Structure and Dynamics 2020; 39(1): 272–284. doi: 10.1080/07391102.2019.1709546
- Deng C, Yan H, Wang J, et al. Current scenario on non-nucleoside reverse transcriptase inhibitors (2018-present). Arabian Journal of Chemistry 2022; 15(12): 104378. doi: 10.1016/j.arabjc.2022.104378
- Nanor E, Agbesi VK, Wu WP, et al. Featurization of drug compounds and target proteins for drug-target interaction prediction. International Journal of Scientific and Research Publications 2020; 10(2): 9813. doi: 10.29322/ijsrp.10.02.2020.p9813
- Firdaus Begam B, Satheesh Kumar J. A study on cheminformatics and its applications on modern drug discovery. Procedia Engineering 2012; 38: 1264–1275. doi: 10.1016/j.proeng.2012.06.156
- Dobson CM. Chemical space and biology. Nature 2004; 432(7019): 824–828. doi: 10.1038/nature03192
- Rahman SA, Bashton M, Holliday GL, et al. Small Molecule Subgraph Detector (SMSD) toolkit. Journal of Cheminformatics 2009; 1(1): 12. doi: 10.1186/1758-2946-1-12
- Lakshmi V, Kannan VS, Boopathy R. Identification of potential bivalent inhibitors from natural compounds for acetylcholinesterase through in silico screening using multiple pharmacophores. Journal of Molecular Graphics and Modelling 2013; 40: 72–79. doi: 10.1016/j.jmgm.2012.12.008
- Dixon SL, Smondyrev AM, Rao SN. Phase: A novel approach to pharmacophore modeling and 3D database searching. Chemical Biology & Drug Design 2006; 67(5): 370–372. doi: 10.1111/j.1747-0285.2006.00384.x
- Leemans E, Mahasenan KV, Kumarasiri M, et al. Three-dimensional QSAR analysis and design of new 1,2,4-oxadiazole antibacterials. Bioorganic & Medicinal Chemistry Letters 2016; 26(3): 1011–1015. doi: 10.1016/j.bmcl.2015.12.041
- Li YP, Weng X, Ning FX, et al. 3D-QSAR studies of azaoxoisoaporphine, oxoaporphine, and oxoisoaporphine derivatives as anti-AChE and anti-AD agents by the CoMFA method. Journal of Molecular Graphics and Modelling 2013; 41: 61–67. doi: 10.1016/j.jmgm.2013.02.003
- Wold S, Ruhe A, Wold H, et al. The collinearity problem in linear regression. The Partial Least Squares (PLS) approach to generalized inverses. SIAM Journal on Scientific and Statistical Computing 1984; 5(3): 735–743. doi: 10.1137/0905052
- Gonzalez-Diaz H, Prado-Prado F, Ubeira F. Predicting antimicrobial drugs and targets with the MARCH-INSIDE approach. Current Topics in Medicinal Chemistry 2008; 8(18): 1676–1690. doi: 10.2174/156802608786786543
- Prado-Prado F, Garcia-Mera X, Escobar M, et al. 3D MI-DRAGON: New model for the reconstruction of US FDA drug- target network and theoretical-experimental studies of inhibitors of rasagiline derivatives for AChE. Current Topics in Medicinal Chemistry 2012; 12(16): 1843–1865. doi: 10.2174/1568026611209061843
- Zanni R, Garcia-Domenech R, Galvez-Llompart M, et al. Alzheimer: A decade of drug design. Why molecular topology can be an extra edge? Current Neuropharmacology 2018; 16(6): 849–864. doi: 10.2174/1570159x15666171129102042
- Nikolic K, Agbaba D, Stark H. Pharmacophore modeling, drug design and virtual screening on multi-targeting procognitive agents approaching histaminergic pathways. Journal of the Taiwan Institute of Chemical Engineers 2015; 46: 15–29. doi: 10.1016/j.jtice.2014.09.017
- Durán Á, Zamora I, Pastor M. Suitability of GRIND-based principal properties for the description of molecular similarity and ligand-based virtual screening. Journal of Chemical Information and Modeling 2009; 49(9): 2129–2138. doi: 10.1021/ci900228x
- Bautista-Aguilera OM, Esteban G, Bolea I, et al. Design, synthesis, pharmacological evaluation, QSAR analysis, molecular modeling and ADMET of novel donepezil-indolyl hybrids as multipotent cholinesterase/monoamine oxidase inhibitors for the potential treatment of Alzheimer’s disease. European Journal of Medicinal Chemistry 2014; 75: 82–95. doi: 10.1016/j.ejmech.2013.12.028
- Daidone F, Montioli R, Paiardini A, et al. Identification by virtual screening and in vitro testing of human DOPA decarboxylase inhibitors. PLoS One 2012; 7(2): e31610. doi: 10.1371/journal.pone.0031610
- Ul-Haq Z, Wilson AK. Frontiers in Computational Chemistry: Volume 6. Bentham Science Publishers; 2022.
- Geldenhuys WJ, Kuzenko SR, Simmons MA. Virtual screening to identify novel antagonists for the G protein-coupled NK3 receptor. Journal of Medicinal Chemistry 2010; 53(22): 8080–8088. doi: 10.1021/jm1010012
- Lešnik S, Štular T, Brus B, et al. LiSiCA: a software for ligand-based virtual screening and its application for the discovery of butyrylcholinesterase inhibitors. Journal of Chemical Information and Modeling 2015; 55(8): 1521–1528. doi: 10.1021/acs.jcim.5b00136
- Dai W, Guo D. A ligand-based virtual screening method using direct quantification of generalization ability. Molecules 2019; 24(13): 2414. doi: 10.3390/molecules24132414
- Sirci F, Istyastono EP, Vischer HF, et al. Virtual fragment screening: Discovery of histamine H3 receptor ligands using ligand-based and protein-based molecular fingerprints. Journal of Chemical Information and Modeling 2012; 52(12): 3308–3324. doi: 10.1021/ci3004094
- Gibbons GS, Chakraborty A, Grigsby SM, et al. Identification of DOT1L inhibitors by structure-based virtual screening adapted from a nucleoside-focused library. European Journal of Medicinal Chemistry 2020; 189: 112023. doi: 10.1016/j.ejmech.2019.112023
- Dobi K, Flachner B, Pukáncsik M, et al. Combination of pharmacophore matching, 2D similarity search, and in vitro biological assays in the selection of potential 5-HT6 antagonists from large commercial repositories. Chemical Biology & Drug Design 2015; 86(4): 864–880. doi: 10.1111/cbdd.12563
- Scotti L, Mendonca Junior FJB, Ishiki HM, et al. Docking studies for multi-target drugs. Current Drug Targets 2017; 18(5): 592–604.
- Lengauer T, Rarey M. Computational methods for biomolecular docking. Current Opinion in Structural Biology 1996; 6(3): 402–406. doi: 10.1016/s0959-440x(96)80061-3
- Kitchen DB, Decornez H, Furr JR, et al. Docking and scoring in virtual screening for drug discovery: Methods and applications. Nature Reviews Drug Discovery 2004; 3(11): 935–949. doi: 10.1038/nrd1549
- Kong B, Wang E, Li Z, et al. Study on the feature of electromagnetic radiation under coal oxidation and temperature rise based on multifractal theory. Fractals 2019; 27(3): 1950038. doi: 10.1142/s0218348x19500385
- Kitchen DB, Decornez H, Furr JR, et al. Docking and scoring in virtual screening for drug discovery: Methods and applications. Nature Reviews Drug Discovery 2004; 3(11): 935–949. doi: 10.1038/nrd1549
- Roy S, Kumar A, Baig MH, et al. Virtual screening, ADMET profiling, molecular docking and dynamics approaches to search for potent selective natural molecules based inhibitors against metallothionein-III to study Alzheimer’s disease. Methods 2015; 83: 105–110. doi: 10.1016/j.ymeth.2015.04.021
- Bautista-Aguilera OM, Samadi A, Chioua M, et al. N-methyl-N-((1-methyl-5-(3-(1-(2-methylbenzyl)piperidin-4-yl)propoxy)-1H-indol-2-yl)methyl)prop-2-yn-1-amine, a new cholinesterase and monoamine oxidase dual inhibitor. Journal of Medicinal Chemistry 2014; 57(24): 10455–10463. doi: 10.1021/jm501501a
- Yelekçi K, Büyüktürk B, Kayrak N. In silico identification of novel and selective monoamine oxidase B inhibitors. Journal of Neural Transmission 2013; 120(6): 853–858. doi: 10.1007/s00702-012-0954-0
- Evranos-Aksöz B, Baysal İ, Yabanoğlu-Çiftçi S, et al. Synthesis and screening of human monoamine oxidase—A inhibitor effect of new 2-pyrazoline and hydrazone derivatives. Archiv der Pharmazie 2015; 348(10): 743–756. doi: 10.1002/ardp.201500212
- Park H, Eom JW, Kim YH. Consensus scoring approach to identify the inhibitors of AMP-activated protein kinase α2 with virtual screening. Journal of Chemical Information and Modeling 2014; 54(7): 2139–2146. doi: 10.1021/ci500214e
- Goldman BB, Wipke WT. QSD quadratic shape descriptors. 2. Molecular docking using quadratic shape descriptors (QSDock). Proteins: Structure, Function, and Genetics 2000; 38(1): 79–94. doi: 10.1002/(sici)1097-0134(20000101)38: 1<79: : aid-prot9>3.0.co, 2-u
- Meng EC, Shoichet BK, Kuntz ID. Automated docking with grid‐based energy evaluation. Journal of Computational Chemistry 1992; 13(4): 505–524. doi: 10.1002/jcc.540130412
- Morris GM, Goodsell DS, Halliday RS, et al. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. Journal of Computational Chemistry 2014; 19(14): 1639–1662. doi: 10.1002/(sici)1096-987x(19981115)19: 14<1639: : aid-jcc10>3.0.co, 2-b
- Feig M, Onufriev A, Lee MS, et al. Performance comparison of generalized born and poisson methods in the calculation of electrostatic solvation energies for protein structures. Journal of Computational Chemistry 2004; 25(2): 265–284. doi: 10.1002/jcc.10378
- Katsnelson A, De Strooper B, Zoghbi HY. Neurodegeneration: From cellular concepts to clinical applications. Science Translational Medicine 2016; 8(364): 364ps18. doi: 10.1126/scitranslmed.aal2074
- Ekor M. The growing use of herbal medicines: Issues relating to adverse reactions and challenges in monitoring safety. Frontiers in Neurology 2014; 4: 177. doi: 10.3389/fphar.2013.00177
- Bandaranayake WM. Quality Control, screening, toxicity, and regulation of herbal drugs. In: Modern Phytomedicine: Turning Medicinal Plants into Drugs. Wiley-VCH Verlag; 2006; pp. 25–57.
- Di Paolo M, Papi L, Gori F, et al. Natural products in neurodegenerative diseases: A great promise but an ethical challenge. International Journal of Molecular Sciences 2019; 20(20): 5170. doi: 10.3390/ijms20205170
- Rahman MH, Bajgai J, Fadriquela A, et al. Redox effects of molecular hydrogen and its therapeutic efficacy in the treatment of neurodegenerative diseases. Processes 2021; 9(2): 308. doi: 10.3390/pr9020308
- Rahman MH, Akter R, Kamal MA. Prospective function of different antioxidant containing natural products in the treatment of neurodegenerative disease. CNS & Neurological Disorders—Drug Targets 2021; 20(8): 694–703. doi: 10.2174/1871527319666200722153611
- Parvez MK. Natural or plant products for the treatment of neurological disorders: Current knowledge. Current Drug Metabolism 2018; 19(5): 424–428. doi: 10.2174/1389200218666170710190249
- Dadhania VP, Trivedi PP, Vikram A, Tripathi DN. Nutraceuticals against neurodegeneration: A mechanistic insight. Current Neuropharmacology 2016; 14(6): 627–640. doi: 10.2174/1570159X14666160104142223
- Rasool M, Malik A, Qureshi MS, et al. Recent updates in the treatment of neurodegenerative disorders using natural compounds. Evidence-Based Complementary and Alternative Medicine 2014; 2014: 1–7. doi: 10.1155/2014/979730
- Leonoudakis D, Rane A, Angeli S, et al. Anti-inflammatory and neuroprotective role of natural product securinine in activated glial cells: implications for Parkinson’s disease. Mediators of Inflammation 2017; 2017: 1–11. doi: 10.1155/2017/8302636
- Paolo MD, Papi L, Gori F, et al. Natural Products in Neurodegenerative Diseases: A Great Promise but an Ethical Challenge. International Journal of Molecular Sciences 2019; 20(20): 5170. doi: 10.3390/ijms20205170
- Starkov AA, Beal FM. Portal to Alzheimer’s disease. Nature Medicine 2008; 14(10): 1020–1021. doi: 10.1038/nm1008-1020
- Venkatesan R, Ji E, Kim SY. Phytochemicals that regulate neurodegenerative disease by targeting neurotrophins: A comprehensive review. BioMed Research International 2015; 2015: 1–22. doi: 10.1155/2015/814068
- Singh A, Deshpande P, Gogia N. Exploring the efficacy of natural products in alleviating Alzheimer’s disease. Neural Regeneration Research 2019; 14(8): 1321. doi: 10.4103/1673-5374.253509
- Wollen KA. Alzheimer’s disease: The pros and cons of pharmaceutical, nutritional, botanical, and stimulatory therapies, with a discussion of treatment strategies from the perspective of patients and practitioners. Alternative Medicine Review 2010; 15(3): 223–244.
- Chahal R, Nanda A, Akkol EK, et al. Ageratum conyzoides L. And its secondary metabolites in the management of different fungal pathogens. Molecules 2021; 26(10): 2933. doi: 10.3390/molecules26102933
- Rahman MA, Rahman MH, Hossain MS, et al. Molecular insights into the multifunctional role of natural compounds: Autophagy modulation and cancer prevention. Biomedicines 2020; 8(11): 517. doi: 10.3390/biomedicines8110517
- Deshpande P, Gogia N, Singh A. Exploring the efficacy of natural products in alleviating Alzheimer’s disease. Neural Regeneration Research 2019; 14(8): 1321–1329. doi: 10.4103/1673-5374.253509
- Sarkar A, Gogia N, Glenn N, et al. A soy protein Lunasin can ameliorate amyloid-beta 42 mediated neurodegeneration in Drosophila eye. Scientific Reports 2018; 8(1): 13545. doi: 10.1038/s41598-018-31787-7
- Hoppe J, Coradini K, Frozza R, et al. Free and nanoencapsulated curcumin suppress β-amyloid-induced cognitive impairments in rats: Involvement of BDNF and Akt/GSK-3β signaling pathway. Neurobiology of Learning and Memory 2013; 106: 134–144. doi: 10.1016/j.nlm.2013.08.001
- Doggui S, Belkacemi A, Paka GD, et al. Curcumin protects neuronal-like cells against acrolein by restoring Akt and redox signaling pathways. Molecular Nutrition & Food Research 2013; 57(9): 1660–1670. doi: 10.1002/mnfr.201300130
- Auti ST, Kulkarni YA. A systematic review on the role of natural products in modulating the pathways in alzheimer’s disease. International Journal for Vitamin and Nutrition Research 2017; 87(1–2): 99–116. doi: 10.1024/0300-9831/a000405
- Zangara A. The psychopharmacology of huperzine A: An alkaloid with cognitive enhancing and neuroprotective properties of interest in the treatment of Alzheimer’s disease. Pharmacology Biochemistry and Behavior 2003; 75(3): 675–686. doi: 10.1016/s0091-3057(03)00111-4
- Kim JI, Jeon SG, Kim KA, et al. Platycodon grandiflorus root extract improves learning and memory by enhancing synaptogenesis in mice hippocampus. Nutrients 2017; 9(7): 794. doi: 10.3390/nu9070794
- Uddin MS, Kabir MT, Rahman MH, et al. Exploring the multifunctional neuroprotective promise of rasagiline derivatives for multi-dysfunctional Alzheimer’s disease. Current Pharmaceutical Design 2020; 26(37): 4690–4698. doi: 10.2174/1381612826666200406075044
- Bagli E, Goussia A, Moschos MM, et al. Natural compounds and neuroprotection: Mechanisms of action and novel delivery systems. In Vivo 2016; 30(5): 535–547.
- Zhao J, Li K, Wang Y, et al. Enhanced anti-amnestic effect of donepezil by Ginkgo biloba extract (EGb 761) via further improvement in pro-cholinergic and antioxidative activities. Journal of Ethnopharmacology 2021; 269: 113711. doi: 10.1016/j.jep.2020.113711
- Devinsky O, Marsh E, Friedman D, et al. Cannabidiol in patients with treatment-resistant epilepsy: An open-label interventional trial. The Lancet Neurology 2016; 15(3): 270–278. doi: 10.1016/s1474-4422(15)00379-8
- Russo EB. The case for the entourage effect and conventional breeding of clinical cannabis: No “Strain,” no gain. Frontiers in Plant Science 2019; 9: 1969. doi: 10.3389/fpls.2018.01969
- Brouwer MC, Thwaites GE, Tunkel AR, et al. Dilemmas in the diagnosis of acute community-acquired bacterial meningitis. The Lancet 2012; 380(9854): 1684–1692. doi: 10.1016/s0140-6736(12)61185-4
- Kim SR, Shin YS, Kim JH, et al. Differences in type composition of symptom clusters as predictors of quality of life in patients with meningioma and glioma. World Neurosurgery 2017; 98: 50–59. doi: 10.1016/j.wneu.2016.10.085
- Koushki M, Amiri‐Dashatan N, Ahmadi N, et al. Resveratrol: A miraculous natural compound for diseases treatment. Food Science & Nutrition 2018; 6(8): 2473–2490. doi: 10.1002/fsn3.855
- Gatson JW, Liu MM, Abdelfattah K, et al. Resveratrol decreases inflammation in the brain of mice with mild traumatic brain injury. Journal of Trauma and Acute Care Surgery 2013; 74(2): 470–475. doi: 10.1097/ta.0b013e31827e1f51
- Maté J, Periago PM, Palop A. When nanoemulsified, d-limonene reduces Listeria monocytogenes heat resistance about one hundred times. Food Control 2016; 59: 824–828. doi: 10.1016/j.foodcont.2015.07.020
- Ars M, Jras P. A new scenario of bioprospecting of Hymenoptera venoms through proteomic approach. The Journal of Venomous Animals and Toxins including Tropical Diseases 2011; 17(4): 364–377. doi: 10.1590/s1678-91992011000400003
- Kim HJ, Jeon BS. Is acupuncture efficacious therapy in Parkinson’s disease? Journal of the Neurological Sciences 2014; 341(1–2): 1–7. doi: 10.1016/j.jns.2014.04.016
- Yang EJ, Jiang JH, Lee SM, et al. Bee venom attenuates neuroinflammatory events and extends survival in amyotrophic lateral sclerosis models. Journal of Neuroinflammation 2010; 7(1): 69. doi: 10.1186/1742-2094-7-69
- Castro HJ, Mendez-Inocencio JI, Omidvar B. A phase I study of the safety of honeybee venom extract as a possible treatment for patients with progressive forms of multiple sclerosis. 2005; 26(6): 470–476.
- Jung SY, Lee KW, Choi SM, et al. Bee venom protects against rotenone-induced cell death in NSC34 motor neuron cells. Toxins 2015; 7(9): 3715–3726. doi: 10.3390/toxins7093715
- Zivkovic AR, Sedlaczek O, von Haken R, et al. Muscarinic M1 receptors modulate endotoxemia-induced loss of synaptic plasticity. Acta Neuropathologica Communications 2015; 3(1): 67. doi: 10.1186/s40478-015-0245-8
- Baudier J, Mochly-Rosen D, Newton A, et al. Comparison of S100b protein with calmodulin: Interactions with melittin and microtubule-associated τ proteins and inhibition of phosphorylation of τ proteins by protein kinase C†. Biochemistry 1987; 26(10): 2886–2893. doi: 10.1021/bi00384a033
- Tohkin M, Yagami T, Matsubara T. Mastoparan, a peptide toxin from wasp venom, stimulates glycogenolysis mediated by an increase of the cytosolic free Ca2+ concentration but not by an increase of cAMP in rat hepatocytes. FEBS Letters 1990; 260(2): 179–182. doi: 10.1016/0014-5793(90)80098-4
- Polanski J. Chemoinformatics. Comprehensive Chemometrics 2009; 4: 459–506. doi: 10.1016/b978-044452701-1.00006-5
- Parzen E. On estimation of a probability density function and mode. The Annals of Mathematical Statistics 1962; 33(3): 1065–1076. doi: 10.1214/aoms/1177704472
- Elabar S. Review on multitarget drug design based on computational strategies for the treatment of Alzheimer’s disease. AlQalam Journal of Medical and Applied Sciences 2021; 4(2): 181–190.
- AZO Life Sciences. How is chemoinformatics used in drug discovery? Available online: https://www.azolifesciences.com/article/How-is-Chemoinformatics-Used-in-Drug-Discovery.aspx (accessed on 10 March 2023).
- Cummings J, Lee G, Zhong K, et al. Alzheimer’s disease drug development pipeline: 2021. Alzheimer’s Dementia. Translational Research & Clinical Interventions 2021; 7(1): e12179. doi: 10.1002/trc2.12179
- Alzheimer’s Association. What is Alzheimer’s disease? Available online: https://www.alz.org/alzheimers-dementia/what-is-alzheimers (accessed on 10 March 2023).
- National Institute on Aging. Alzheimer’s disease fact sheet. Available online: https://www.nia.nih.gov/health/alzheimers-disease-fact-sheet (accessed on 10 March 2023).
- Cummings J, Lee G, Zhong K, et al. Alzheimer’s disease drug development pipeline: 2021. Alzheimer’s & Dementia: Translational Research & Clinical Interventions 2021; 7(1): 12179. doi: 10.1002/trc2.12179
- WHO. Dementia. Available online: https://www.who.int/news-room/fact-sheets/detail/dementia (acceesed on 10 March 2023).
- Fortalezas S, Tavares L, Pimpão R, et al. Antioxidant properties and neuroprotective capacity of strawberry tree fruit (Arbutus unedo). Nutrients 2010; 2(2): 214–229. doi: 10.3390/nu2020214
- Essa MM, Vijayan RK, Castellano-Gonzalez G, et al. Neuroprotective effect of natural products against Alzheimer’s disease. Neurochemical Research 2012; 37(9): 1829–1842. doi: 10.1007/s11064-012-0799-9
- Wang J, Ho L, Zhao W, et al. Grape-derived polyphenolics prevent Aβ oligomerization and attenuate cognitive deterioration in a mouse model of Alzheimer’s disease. Journal of Neuroscience 2008; 28(25): 6388–6392. doi: 10.1523/jneurosci.0364-08.2008
- ScienceDirect. Grape seed extract—An overview. Available online: https://www.sciencedirect.com/topics/medicine-and-dentistry/grape-seed-extract (accessed on 10 March 2023).
- Zhang J, Mori A, Chen Q, et al. Fermented papaya preparation attenuates β-amyloid precursor protein: β-amyloid-mediated copper neurotoxicity in β-amyloid precursor protein and β-amyloid precursor protein Swedish mutation overexpressing SH-SY5Y cells. Neuroscience 2006; 143(1): 63–72. doi: 10.1016/j.neuroscience.2006.07.023
- Barbagallo M, Marotta F, Dominguez LJ. Oxidative stress in patients with Alzheimer’s disease: Effect of extracts of fermented papaya powder. Mediators of Inflammation 2015; 2015: 1–6. doi: 10.1155/2015/624801.
- Weinreb O, Mandel S, Amit T, et al. Neurological mechanisms of green tea polyphenols in Alzheimer’s and Parkinson’s diseases. The Journal of Nutritional Biochemistry 2004; 15(9): 506–516. doi: 10.1016/j.jnutbio.2004.05.002
- Zhu Y, Wendler CC, Shi O, et al. Diazoxide promotes oligodendrocyte differentiation in neonatal brain in normoxia and chronic sublethal hypoxia. Brain Research 2014; 1586: 64–72. doi: 10.1016/j.brainres.2014.08.046
- Basith S, Cui M, Macalino SJY, et al. Exploring G protein-coupled receptors (GPCRs) ligand space via cheminformatics approaches: Impact on rational drug design. Frontiers in Pharmacology 2018; 9: 128. doi: 10.3389/fphar.2018.00128
- Davie CA. A review of Parkinson’s disease. British Medical Bulletin 2008; 86(1): 109–127. doi: 10.1093/bmb/ldn013
- Dickson DW. Parkinson’s disease and parkinsonism: Neuropathology. Cold Spring Harbor Perspectives in Medicine 2012; 2(8): a009258. doi: 10.1101/cshperspect.a009258
- Bose A, Beal MF. Mitochondrial dysfunction in Parkinson’s disease. Journal of Neurochemistry 2016; 139(S1): 216–231. doi: 10.1111/jnc.13731
- Foley PB, Hare DJ, Double KL. A brief history of brain iron accumulation in Parkinson disease and related disorders. Journal of Neural Transmission 2022; 129(5–6): 505–520. doi: 10.1007/s00702-022-02505-5
- Qu Y, Li J, Qin Q, et al. A systematic review and meta-analysis of inflammatory biomarkers in Parkinson’s disease. NPJ Parkinson’s Disease 2023; 9(1): 18. doi: 10.1038/s41531-023-00449-5
- Repetto MG, Domínguez RO, Marschoff ER, et al. Free radicals, oxidative stress and oxidative damage in Parkinson’s disease. In: Dushanova J (editor). Mechanisms in Parkinson’s Disease—Models and Treatments. IntechOpen; 2012; pp. 57–58.
- Solayman M, Islam M, Alam F, et al. Natural products combating neurodegeneration: Parkinson’s disease. Current Drug Metabolism 2017; 18(1): 50–61. doi: 10.2174/1389200217666160709204826
- Novak V, Rogelj B, Antioxidants V, et al. Therapeutic potential of polyphenols in amyotrophic lateral sclerosis and frontotemporal dementia. Antioxidants 2021; 10(8): 1328. doi: 10.3390/antiox10081328
- Mansuri ML, Parihar P, Solanki I, et al. Flavonoids in modulation of cell survival signalling pathways. Genes & Nutrition 2014; 9(3): 400. doi: 10.1007/s12263-014-0400-z
- Dawson TM, Dawson VL. Molecular pathways of neurodegeneration in Parkinson’s disease. Science 2003; 302(5646): 819–822. doi: 10.1126/science.1087753
- Ma Z, Liu H, Wu B. Structure-based drug design of catechol-O-methyltransferase inhibitors for CNS disorders. British Journal of Clinical Pharmacology 2014; 77(3): 410–420. doi: 10.1111/bcp.12169
- Lemańska K, van der Woude H, Szymusiak H, et al. The effect of catechol O-methylation on radical scavenging characteristics of quercetin and luteolin—A mechanistic insight. Free Radical Research 2004; 38(6): 639–647. doi: 10.1080/10715760410001694062
- Nagappan P, Krishnamurthy V. Structural prediction and comparative molecular docking studies of hesperidin and l-dopa on α-synuclein, MAO-B, COMT and UCHL-1 inhibitors. International Journal of Pharmaceutical and Clinical Research 2015; 7(3): 221–225.
- Schultz E. Catechol-O-methyltransferase and aromatic L-amino acid decarboxylase activities in human gastrointestinal tissues. Life Sciences 1991; 49(10): 721–725. doi: 10.1016/0024-3205(91)90104-j
- Parsons MP, Raymond LA. Huntington disease. In: Zigmond MJ, Rowland LP, Coyle JT (editors). Neurobiology of Brain Disorders—Biological Basis of Neurological and Psychiatric Disorders. Academic Press; 2015. pp. 303–320.
- Gatto EM, Rojas NG, Persi G, et al. Huntington disease: Advances in the understanding of its mechanisms. Clinical Parkinsonism & Related Disorders 2020; 3: 100056. doi: 10.1016/j.prdoa.2020.100056
- Hamilton PJ, Lim CJ, Nestler EJ, et al. Neuroepigenetic editing. Methods in Molecular Biology 2018; 1767: 113–136. doi: 10.1007/978-1-4939-7774-1_5
- Lee JM, Wheeler VC, Chao MJ, et al. Identification of genetic factors that modify clinical onset of Huntington’s disease. Cell 2015; 162(3): 516–526. doi: 10.1016/j.cell.2015.07.003
- Colpo GD, Furr Stimming E, Teixeira AL. Stem cells in animal models of Huntington disease: A systematic review. Molecular and Cellular Neuroscience 2019; 95: 43–50. doi: 10.1016/j.mcn.2019.01.006
- Komatsu H. Innovative therapeutic approaches for Huntington’s disease: From nucleic acids to GPCR-targeting small molecules. Frontiers in Cellular Neuroscience 2021; 15: 785703. doi: 10.3389/fncel.2021.785703
- Godino L, Turchetti D, Jackson L, et al. Impact of presymptomatic genetic testing on young adults: A systematic review. European Journal of Human Genetics 2015; 24(4): 496–503. doi: 10.1038/ejhg.2015.153
- Pham HTN, Tran HN, Nguyenet PT, et al. Bacopa monnieri (L.) Wettst. Extract improves memory performance via promotion of neurogenesis in the hippocampal dentate gyrus of adolescent mice. International Journal of Molecular Science 2020; 21(9): 3365. doi: 10.3390/ijms21093365
- Purusothaman D, Chalichem NSS, Bethapudi B, et al. Bacopa monnieri for cognitive health—A review of molecular mechanisms of action. In: Nutraceuticals in Brain Health and Beyond. Academic Press; 2021; pp. 15–30.
- Lorca C, Mulet M, Arévalo-Caro C, et al. Plant-derived nootropics and human cognition: A systematic review. Critical Reviews in Food Science and Nutrition 2022; 63(22): 5521–5545. doi: 10.1080/10408398.2021.2021137
- Sukumaran NP, Amalraj A, Gopi S. Neuropharmacological and cognitive effects of Bacopa monnieri (L.) Wettst—A review on its mechanistic aspects. Complementary Therapies in Medicine 2019; 44: 68–82. doi: 10.1016/j.ctim.2019.03.016
- Fatima U, Roy S, Ahmad S, et al. Pharmacological attributes of Bacopa monnieri extract: Current updates and clinical manifestation. Frontiers in Nutrition 2022; 9: 972379. doi: 10.3389/fnut.2022.972379
- Basheer A, Agarwal A, Mishra B, et al. Use of Bacopa monnieri in the Treatment of Dementia due to Alzheimer disease: Systematic review of randomized controlled trials. Interactive Journal of Medical Research 2022; 11(2): e38542. doi: 10.2196/38542
- Qi LW, Wang CZ, Yuan CS. Ginsenosides from American ginseng: Chemical and pharmacological diversity. Phytochemistry 2011; 72(8): 689–699. doi: 10.1016/j.phytochem.2011.02.012
- Yang X, Chu SF, Wang ZZ, et al. Ginsenoside Rg1 exerts neuroprotective effects in 3-nitropronpionic acid-induced mouse model of Huntington’s disease via suppressing MAPKs and NF-κB pathways in the striatum. Acta Pharmacologica Sinica 2021; 42(9): 1409–1421. doi: 10.1038/s41401-020-00558-4
- Huang X, Li N, Pu Y, et al. Neuroprotective effects of ginseng phytochemicals: Recent perspectives. Molecules 2019; 24(16): 2939. doi: 10.3390/molecules24162939
- Schäfer T, Kriege N, Humbeck L, et al. Scaffold hunter: A comprehensive visual analytics framework for drug discovery. Journal of Cheminformatics 2017; 9(1): 28. doi: 10.1186/s13321-017-0213-3
- Ahmad I, Kumar D, Patel H. Computational investigation of phytochemicals from Withania somnifera (Indian ginseng/ashwagandha) as plausible inhibitors of GluN2B-containing NMDA receptors. Journal of Biomolecular Structure and Dynamics 2021; 40(17): 7991–8003. doi: 10.1080/07391102.2021.1905553
- Zakaryan H, Arabyan E, Oo A, et al. Flavonoids: Promising natural compounds against viral infections. Archives of Virology 2017; 162(9): 2539–2551. doi: 10.1007/s00705-017-3417-y
- Niu Y, Chen J, Fan Y, et al. Effect of flavonoids from Lycium barbarum leaves on the oxidation of myofibrillar proteins in minced mutton during chilled storage. Journal of Food Science 2021; 86(5): 1766–1777. doi: 10.1111/1750-3841.15728
- Ishola AA, Oyinloye BE, Ajiboye BO, et al. Molecular docking studies of flavonoids from Andrographis paniculata as potential acetylcholinesterase, butyrylcholinesterase and monoamine oxidase inhibitors towards the treatment of neurodegenerative diseases. Biointerface Research in Applied Chemistry 2020; 11(3): 9871–9879. doi: 10.33263/briac113.98719879
- Yang H, Chen D, Cui QC, et al. Celastrol, a triterpene extracted from the Chinese “Thunder of God Vine,” is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice. Cancer Research 2006; 66(9): 4758–4765. doi: 10.1158/0008-5472.can-05-4529
- Lin MW, Lin CC, Chen YH, et al. Celastrol inhibits dopaminergic neuronal death of Parkinson’s disease through activating mitophagy. Antioxidants 2019; 9(1): 37. doi: 10.3390/antiox9010037
- Cleren C, Calingasan NY, Chen J, et al. Celastrol protects against MPTP- and 3-nitropropionic acid-induced neurotoxicity. Journal of Neurochemistry 2005; 94(4): 995–1004. doi: 10.1111/j.1471-4159.2005.03253.x
- Ansar AFM, Souza IS, Chiang KJ, Haiman Z. Effects of multiple sclerosis on locomotor pattern generation. Available online: https://isn.ucsd.edu/courses/beng260/2017/reports/2017_Group8.pdf (accessed on 11 March 2023).
- Filippini G, Lasserson TJ, Dwan K, et al. Cannabis and cannabinoids for people with multiple sclerosis. Cochrane Cochrane Database of Systematic Reviews 2019; 2019(10): CD013444. doi: 10.1002/14651858.CD013444
- Cree BAC, Bennett JL, Kim HJ, et al. Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): A double-blind, randomised placebo-controlled phase 2/3 trial. The Lancet 2019; 394(10206): 1352–1363. doi: 10.1016/s0140-6736(19)31817-3
- Nabavi S, Daglia M, D’Antona G, et al. Natural compounds used as therapies targeting to amyotrophic lateral sclerosis. Current Pharmaceutical Biotechnology 2015; 16(3): 211–218. doi: 10.2174/1389201016666150118132224
- Singh B, Kaur P, Gopichand, et al. Biology and chemistry of Ginkgo biloba. Fitoterapia 2008; 79(6): 401–418. doi: 10.1016/j.fitote.2008.05.007
- Singh SK, Srivastav S, Castellani RJ, et al. Neuroprotective and antioxidant effect of ginkgo biloba extract against AD and other neurological disorders. Neurotherapeutics 2019; 16(3): 666–674. doi: 10.1007/s13311-019-00767-8
- Zheng Y, Xie Y, Qi M, et al. Ginkgo biloba extract is comparable with donepezil in improving functional recovery in Alzheimer’s disease: Results from a multilevel characterized study based on clinical features and resting-state functional magnetic resonance imaging. Frontiers in Pharmacology 2021; 12: 721216. doi: 10.3389/fphar.2021.721216
- Britannica. ginseng. Available online: https://www.britannica.com/plant/ginseng (accessed on 11 March 2023).
- Zhao A, Liu N, Yao M, et al. A review of neuroprotective effects and mechanisms of ginsenosides from Panax ginseng in treating ischemic stroke. Frontiers in Pharmacology 2022; 13: 946752. doi: 10.3389/fphar.2022.946752
- Jang WY, Hwang JY, Cho JY. Ginsenosides from Panax ginseng as key modulators of NF-κB signaling are powerful anti-inflammatory and anticancer agents. International Journal of Molecular Sciences 2023; 24(7): 6119. doi: 10.3390/ijms24076119
- Morshed MN, Ahn JC, Mathiyalagan R, et al. Antioxidant activity of Panax ginseng to regulate ROS in various chronic diseases. Applied Sciences 2023; 13(5): 2893. doi: 10.3390/app13052893
- Polkowski K, Mazurek AP. BIological properties of genistein. A review of in vitro and in vivo data. Acta Poloniae Pharmaceutica 2000; 57(2): 135–155.
- Gan M, Ma J, Chen J, et al. miR-222 is involved in the amelioration effect of genistein on dexamethasone-induced skeletal muscle atrophy. Nutrients 2022; 14(9): 1861. doi: 10.3390/nu14091861
- Rastogi S. Rehabilitative potential of Ayurveda for neurological deficits caused by traumatic spinal cord injury. Journal of Ayurveda and Integrative Medicine 2014; 5(1): 56. doi: 10.4103/0975-9476.128868
- Zucchella C, Sinforiani E, Tamburin S, et al. The multidisciplinary approach to Alzheimer’s disease and dementia. A narrative review of non-pharmacological treatment. Frontiers in Neurology 2018; 9: 1508. doi: 10.3389/fneur.2018.01058
- Cragg GM, Grothaus PG, Newman DJ. Impact of natural products on developing new anti-cancer agents. Chemical Reviews 2009; 109(7): 3012–3043. doi: 10.1021/cr900019j
- Aboulwafa MM, Youssef FS, Gad HA, et al. A comprehensive insight on the health benefits and phytoconstituents of camellia sinensis and recent approaches for its quality control. Antioxidants (Basel) 2019; 8(10): 455. doi: 10.3390/antiox8100455
- Kellogg JJ, Paine MF, McCune JS, et al. Selection and characterization of botanical natural products for research studies: a NaPDI center recommended approach. Natural Product Reports 2019; 36(8): 1196–1221. doi: 10.1039/c8np00065d
- NCCIH. Natural doesn’t necessarily mean safer, or better. Available online: https://www.nccih.nih.gov/health/know-science/natural-doesnt-mean-better (accessed on 15 March 2023).
- Whitcup SM. Clinical trials in neuroprotection. Progress in Brain Research 2008; 173: 323–335. doi: 10.1016/S0079-6123(08)01123-0
- Prasad S, Srivastava A, Singh N, Singh H. Present and future challenges in therapeutic designing using computational approaches. In: Computational Approaches for Novel Therapeutic and Diagnostic Designing to Mitigate SARS-CoV2 Infection. Elsevier; 2022. pp. 489–505.
DOI: https://doi.org/10.24294/ace.v7i1.2140
Refbacks
- There are currently no refbacks.
License URL: https://creativecommons.org/licenses/by-nc/4.0/